Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12615001115527
ACTRN12615001115527
Not yet recruiting
Phase 1

Randomized, Placebo-Controlled Clinical Trial of Transdermal DHT Gel to Improve IVF Outcomes In Women With Poor Ovarian Response

Prof.David Handelsman0 sites242 target enrollmentOctober 22, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Prof.David Handelsman
Enrollment
242
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 22, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Prof.David Handelsman

Eligibility Criteria

Inclusion Criteria

  • •\*Age \>18 years
  • •\*Modified Bologna criteria stratified by age
  • •\-For women \>40 years, no additional inclusion criteria
  • •\-For women \<40 years, at least one additional inclusion criterion either previous IVF cycle with POR (\<3 oocytes with conventional stimulation) and/or impaired ovarian reserve (ultrasonic antral follicle count \<7 follicles or serum AMH \<1\.1 ng/ml)

Exclusion Criteria

  • •\*Use of androgens or pro\-androgens in previous 2 months
  • •\*Perimenopausal (no regular cycle, high serum FSH)
  • •\*Major uterine abnormalities
  • •\*History of untreated systemic medical disease or organ failure (eg impaired cardiac, respiratory, hepatic, or renal function)
  • •\*Extensive skin disease that would interfere with use of the transdermal gel
  • •\*Participation in other clinical trials of medical therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Randomised, placebo-controlled clinical trial on the efficacy of Roleca® juniper 100 mg for dyspeptic digestive complaints such as cramps in the gastrointestinal tract, flatulence and bloating.Treatment of dyspeptic digestive complaints (cramps in the gastrointestinal tract, flatulence, bloating).Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
CTIS2023-504750-35-01CGBS GbR100
Completed
Not Applicable
Randomized, placebo-controlled clinical trial on the efficacy of a mouthrinse containing 0.1% benzalkoniumchloride on the reduction of intraoral viral load and infectivity in SARS-CoV-2 positive subjects (COVID-19)U07.1COVID-19, virus identified
DRKS00024454Poliklinik für Zahnerhaltung und ParodontologieUniversitätsklinikum Regensburg24
Completed
Not Applicable
Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
PER-065-05DRUGS FOR NEGLECTED DISEASE INITIATIVE,
Completed
Phase 2
Efficacy of Gabapentin on flushing in menopausal wome
IRCT201103011107N4Jundishapour Medical University60
Completed
Phase 2
The effect of hydroxyzine on bruxismBruxism.Other somatoform disorders
IRCT201110203930N13Vice chancellor for research, Shiraz University of Medical Sciences30